The role of estradiol in the maintenance of secondary hypogonadism in males in erectile dysfunction.
The occurrence of secondary hypogonadism is a common finding in males who seek help with erectile dysfunction, although the relationship to diminished testosterone is unclear. Two possibilities exist regarding both the genesis and maintenance of the hypogonadotropic hypogonadal state. First, a defect in hypothalamic function, resulting in downregulation as well as in alterations of anterior pituitary function; second, estradiol inhibition of gonadotropin release, both of which result in decreased testosterone production. As testosterone levels decrease and estradiol levels increase, the ratio of free testosterone to estradiol reaches a critical point and the estrogenic gonadotropin suppressive effects predominate. This ratio may signal the biological point of no return and could become one of the criteria for defining the separation of the transitional hypogonadal state from the final 'end stage' hypogonadotropic hypogonadal state. As the aging process continues, there is a relative accumulation of fatty tissue, and aromatization accelerates the conversion of testosterone to estradiol. This additional secondary estradiol inhibition results in the maintenance of the testosterone deficient state, and the aging process continues uncontested.
The Advanced Medical Group, Marietta, GA 30067-0059, USA.
P G
PG
Cohen
D000375:Aging / Q000502:physiology; D007172:Erectile Dysfunction / Q000150:complications / Q000503:physiopathology*; D004958:Estradiol / Q000502:physiology*; D006801:Humans; D007006:Hypogonadism / Q000209:etiology / Q000503:physiopathology*; D007031:Hypothalamus / Q000502:physiology; D008297:Male; D010903:Pituitary Gland, Anterior / Q000502:physiology; D013739:Testosterone / Q000502:physiology
D013739:Testosterone; D004958:Estradiol